0001144204-11-057312.txt : 20111011 0001144204-11-057312.hdr.sgml : 20111010 20111011155113 ACCESSION NUMBER: 0001144204-11-057312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111007 FILED AS OF DATE: 20111011 DATE AS OF CHANGE: 20111011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCUBBIN JAMES T CENTRAL INDEX KEY: 0001257635 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 111135530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 v236788_4.xml OWNERSHIP DOCUMENT X0304 4 2011-10-07 0 0000868278 ProPhase Labs, Inc. PRPH 0001257635 MCCUBBIN JAMES T 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 1 0 0 0 Common Stock, par value $0.0005 2011-10-07 4 A 0 5640 0 A 25103 D These restricted shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan for Board fees payable to non-employee directors. The 2010 Directors' Equity Compensation Plan was approved by the Company's stockholders on May 5, 2010. /s/ James McCubbin 2011-10-07